Everything Blockchain Enters Agreements for Stakes in Five Early-Stage Companies, Prepares CloverMint Stablecoin App for Public Trial
Rhea-AI Summary
Everything Blockchain (OTC: EBZT) entered agreements to acquire 10%–15% stakes in five early-stage AI and crypto companies, selected from over 30 reviewed opportunities; deals remain subject to final diligence and closing conditions. The company also expects CloverMint stablecoin app public trial in early April after two months of private live testing.
CloverMint averaged 8.0% gross annualized in backtesting and 7.5% gross annualized during live testing; the app automates stablecoin yield allocation across DeFi protocols. EBZT said a portfolio update will include details on NoLimit Foundation and other holdings, and it is evaluating a token-related initiative subject to legal and regulatory review.
Positive
- Entered agreements for 10%–15% stakes in five startups
- CloverMint 7.5% gross annualized in live testing
- CloverMint 8.0% gross annualized in backtesting
Negative
- Agreements remain subject to final diligence and closing
- Token-related initiative is subject to legal and regulatory review
- CloverMint public results pending after two months private testing
News Market Reaction – EBZT
On the day this news was published, EBZT gained 159.02%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CloverMint averaged
Jacksonville, FL, April 07, 2026 (GLOBE NEWSWIRE) -- Everything Blockchain Inc. (OTC: EBZT) has entered into agreements for
The portfolio construction milestone is part of EBZT's strategy to become a public-market vehicle for early-stage technology exposure. The Company combines internal product development with strategic ownership stakes in private businesses, giving shareholders access to multiple emerging opportunities through a single publicly traded company.
Separately, the Company's stablecoin app CloverMint is expected to open for public trial in early April after two months of private live testing. Based on internal Company data, CloverMint averaged
Arthur Rozenberg, Chief Executive Officer of Everything Blockchain, said, "CloverMint took longer to launch than we initially expected because we wanted to test the product carefully before releasing it publicly. That additional time allowed us to evaluate performance, refine the experience, and simplify the product ahead of the public trial."
The Company expects its next portfolio update to include details on NoLimit Foundation, a privacy-first AI platform focused on zero data retention and unrestricted model access, along with additional information on the remaining portfolio companies.
The Company is also evaluating a token-related initiative intended to align its ecosystem with shareholders, subject to legal and regulatory requirements.
Upon launch of the public trial, investors and users will be able to learn more about CloverMint at CloverMint.io.
For more information, visit www.everythingblockchain.io
Media Contact:Investor Relations
Everything Blockchain Inc.
Email: arthur.rozenberg@everythingblockchain.io
Website: www.everythingblockchain.io
About Everything Blockchain Inc.
Everything Blockchain Inc. (OTC: EBZT) is a publicly traded company building and backing early-stage businesses across AI and crypto. Through internal product development and strategic ownership stakes, EBZT is building a public startup portfolio designed to give shareholders exposure to emerging technology opportunities.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding CloverMint’s anticipated public availability, the Company’s expected ownership interests in portfolio companies, future portfolio announcements, any potential token-related initiative, and the Company’s long-term business strategy. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. The Company undertakes no obligation to update these statements except as required by law.
Performance, Token, and Transaction Disclosure
Performance figures referenced in this release are based on internal Company data, including internal backtesting and limited private live testing. They are gross annualized figures, have not been audited, and should not be relied upon as indicative of future results. Past performance does not guarantee future results. CloverMint is expected to open in a limited public trial and may be modified, delayed, or discontinued at any time. Any token-related initiative remains subject to further development, board approval, legal review, and applicable regulatory requirements. This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security, token, or other financial instrument. References to agreements for portfolio company interests remain subject to final documentation, diligence, approvals, and closing conditions where applicable.
